查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鈣通道阻滯劑市場與 COVID-19 影響分析，按藥物類別、按應用、按配銷通路、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1339877

鈣通道阻滯劑市場與 COVID-19 影響分析，按藥物類別、按應用、按配銷通路、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Calcium Channel Blockers Market with COVID-19 Impact Analysis, By Drug Class, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 308 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年鈣通道阻滯劑市場規模為 140.051 億美元，2023 年至 2030 年年複合成長率為 6.1%。

鈣通道阻滯劑市場-市場動態：

  • 心血管疾病患病率的上升以及對焦慮症或雙相情感障礙患者的援助的增加預計將推動預測期內的成長。
  • 人們生活方式的改變導致心血管疾病患病率不斷上升，可能會推動鈣通道阻滯劑市場的成長。由於這些疾病會影響心臟或血管並降低心力衰竭和中風的風險，因此使用鈣通道阻滯劑。此外，與心臟病相關的主要原因是高血壓，通常稱為血壓升高。鈣拮抗劑治療該適應症的有效性已得到充分證明。反過來，該市場對改善心血管疾病管理的需求也在穩步成長。然而，鈣通道阻滯劑的副作用，包括頭痛、便秘和水腫，預計將阻礙全球鈣通道阻滯劑市場的需求。此外，鈣通道阻滯劑可能對一小部分沒有心臟問題的人有利。與此相一致的是，一些跡象表明它們可以充當情緒穩定劑並幫助那些患有焦慮症或雙相情感障礙的人。後者正在接受專門研究，因為與大多數傳統的情緒穩定劑或抗精神病藥物相比，一些鈣通道阻滯劑可能更安全地用於孕婦。因此，這些因素為促進鈣通道阻滯劑市場的成長提供了機會。

鈣通道阻滯劑市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，全球鈣通道阻滯劑市場預計在預測期內（2023-2030）每年將以 6.1% 左右的年複合成長率成長
  • 由於心血管疾病患病率不斷上升，鈣通道阻滯劑行業預計將大幅成長
  • 根據藥物類別細分，預計二氫吡啶將在 2022 年佔據最大市場佔有率
  • 根據應用細分，高血壓是預測期內的主要類型
  • 按地區分類，北美是 2022 年的主要收入來源

鈣通道阻滯劑市場-細分分析：

  • 全球鈣通道阻滯劑市場根據藥物類別、應用、配銷通路和地區進行細分。
  • 市場根據藥物類別分為三類：二氫吡啶、苯烷基胺和苯並噻嗪。二氫吡啶部分可能擁有最大的收入佔有率。由於研發活動的增加和製藥行業的擴張，預計該細分市場將出現。此外，該藥物具有良好的血管選擇性以及控制動脈壓和血管阻力的能力，在治療中受到廣泛的青睞。二氫吡啶類藥物包括非洛地平、氨氯地平、尼群地平和尼莫地平。
  • 根據應用，市場分為四類：心絞痛、高血壓、肥厚性心肌病、心律失常等。高血壓細分市場預計將佔據最大的市場佔有率。高血壓會增加心臟、大腦和腎臟問題的風險。基於此，用於治療高血壓的藥物的需求可能會增加。
  • 根據配銷通路，市場分為三類：網上藥店、醫院藥店和零售藥店。在預測期內，零售藥房領域預計將主導市場。不健康的生活方式導致肥胖和心血管疾病的增加。因此，定期開出此類藥物以維持血壓。此外，由於市場供應量的增加和高消費，先天性心臟病、心力衰竭、高血壓和心臟病等心血管疾病病例的不斷增加，也推動了零售藥品的擴張。

鈣通道阻滯劑市場 - 地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

鈣通道阻滯劑市場-競爭格局：

本地和全球公司的存在使得鈣通道阻滯劑市場具有適度的競爭性。主要參與者專注於多種成長戰略，例如合作、產品發布和收購，這些戰略不斷促進鈣通道阻滯劑在全球的成長。此外，隨著世界範圍內心血管疾病病例的不斷增加，主要參與者正在投入大量資金來開發新的療法並在市場上維持自己的地位。醫療基礎設施的改善正在增加對鈣通道阻滯劑的需求。例如，2022年2月，FDA批准了CMP Pharma的Norliqva口服液。此外，該解決方案有助於治療高血壓，降低成人和 6 歲兒童的血壓。 Norliqva 採用 150 毫升瓶裝，有效期為 36 個月

最近的發展：

例如，2021 年 5 月，生物製藥公司 Milestone Pharmaceuticals, Inc. 發布了 Etripamil 3 期 RAPID 臨床試驗的正面安全性和有效性數據。此外，該公司正在研究鈣通道阻滯劑治療陣發性室上性心動過速（PSVT）的患者。

該研究的主要特點：

  • 這項關於鈣通道阻滯劑市場的擬議研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030），以 2022 年為基準年。
  • 該報告為客戶提供了有關鈣通道阻滯劑市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了鈣通道阻滯劑市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、現有參與者面臨的挑戰以及鈣通道阻滯劑市場維持的成長因素。
  • COVID-19 對鈣通道阻滯劑市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將詳細介紹新冠疫情后鈣通道阻滯劑市場的情況。
  • 為了讓本報告的用戶全面了解鈣通道阻滯劑市場，我們還包括了鈣通道阻滯劑市場的競爭格局和關鍵創新者分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這些參與者將幫助用戶了解鈣通道阻滯劑市場參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球鈣通道阻滯劑市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第 1 章：鈣通道阻滯劑市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物類別分類的鈣通道阻滯劑市場片段
    • 鈣通道阻滯劑市場片段（按應用）
    • 按配銷通路分類的鈣通道阻滯劑市場片段
    • 按國家/地區分類的鈣通道阻滯劑市場片段
    • 按地區分類的鈣通道阻滯劑市場片段
  • 競爭洞察

第 3 章：鈣通道阻滯劑主要市場趨勢

  • 鈣通道阻滯劑市場促進因素
    • 市場促進因素的影響分析
  • 鈣通道阻滯劑市場限制
    • 市場限制影響分析
  • 鈣通道阻滯劑的市場機會
  • 鈣通道阻滯劑市場未來趨勢

第 4 章：鈣通道阻滯劑行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：鈣通道阻滯劑市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：鈣通道阻滯劑市場格局

  • 2022 年鈣通道阻滯劑市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：鈣通道阻滯劑市場 - 按藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 二氫吡啶
    • 苯烷基胺
    • 苯並噻嗪

第 8 章：鈣通道阻滯劑市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 心絞痛
    • 高血壓
    • 肥厚型心肌病
    • 心律失常
    • 其他

第 9 章：鈣通道阻滯劑市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 網上藥店
    • 醫院藥房
    • 零售藥店

第 10 章：鈣通道阻滯劑市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 鈣通道阻滯劑北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類別）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 鈣通道阻滯劑歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類別）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 鈣通道阻滯劑亞太地區主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按藥物類別）
    • 亞太地區市場規模和預測（按應用）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 鈣通道阻滯劑拉丁美洲主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按藥物類別）
    • 拉丁美洲市場規模和預測（按應用）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 鈣通道阻滯劑中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類別）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 鈣通道阻滯劑行業

  • 競爭儀表板
  • 公司簡介
    • Bayer
    • Sanofi
    • Wyeth-Ayerst
    • ClearSynth
    • AbMole Bioscience
    • Pfizer
    • Lupin Pharmaceuticals, Inc.
    • Searle
    • Knoll Pharmaceuticals
    • GlaxoSmithKline Plc.
    • Aventis
    • AstraZeneca
    • Novartis

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1601

REPORT HIGHLIGHT

Calcium Channel Blockers Market size was valued at USD 14,005.1 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.

Calcium channel blockers are known as medications that are utilized to maintain high blood pressure, arrhythmia, and chest pain. Additionally, they can be obtained through prescription and work by relaxing blood vessels and improving the heart's blood and oxygen supply. As a result, this helps to minimize the workload of the heart. Moreover, to treat high blood pressure and angina, it may be prescribed by itself or in conjunction with other medications.

Calcium Channel Blockers Market- Market Dynamics:

  • The increasing prevalence rate of cardiovascular diseases and rising assistance to people with anxiety disorders or bipolar disorder is projected to drive growth in the forecast period.
  • The changing lifestyle of people has resulted in the increasing prevalence rate of cardiovascular diseases is likely to fuel the calcium channel blocker market growth. As these diseases impact the heart or blood vessels and lower the risk of heart failure & stroke, calcium channel blockers are used. Additionally, the major causes associated with heart disease are hypertension, often referred to as elevated blood pressure. The effectiveness of calcium antagonists in curing this indication has been well documented. This in turn, the demand has been growing steadily for this market for improved management of cardiovascular diseases. However, side effects concerning calcium channel blockers including headache, constipation, and edema are expected to hinder the demand for calcium channel blocker market globally. Moreover, calcium channel blockers may be advantageous to a smaller group of persons who do not have heart issues. In line with this, some indications they may act as mood stabilizers and assist those people who suffer from anxiety disorders or bipolar disorder. The latter is specifically under investigation because some calcium channel blockers may be more secure to administer to pregnant women as compared to most traditional mood stabilizers or antipsychotics. Thus, such factors offer opportunity to increase the growth of the calcium channel blocker market.

Calcium Channel Blockers Market- Key Insights:

  • As per the analysis shared by our research analyst, the global calcium channel blocker market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2023-2030)
  • The calcium channel blocker industry is projected to grow at a significant rate due to the increasing prevalence rate of cardiovascular diseases
  • Based on drug class segmentation, dihydropyridine was predicted to show maximum market share in the year 2022
  • Based on application segmentation, hypertension was the leading type over the forecast period
  • On the basis of region, North America was the leading revenue generator in 2022

Calcium Channel Blockers Market- Segmentation Analysis:

  • The global calcium channel blockers market is segmented on the basis of drug class, application, distribution channel, and region.
  • The market is divided into three categories based on drug class: dihydropyridine, phenylalkylamine, and benzothizepine. The dihydropyridine segment is likely to possess the largest revenue share. The segment is anticipated due to the increasing research & development activities and expansion in the pharmaceutical industry. Moreover, the drug has great vascular selectivity and the capacity to control arterial pressure and vascular resistance, which is widely preferred in therapeutics. Dihydropyridine drugs include felodipine, amlodipine, nitrendipine, and nimodipine.
  • The market is divided into four categories based on application: angina, hypertension, hypertrophic cardiomyopathy, arrhythmia, and others. The hypertension segment is expected to hold the largest market share. The hypertension segment raises the risk of heart, brain, and renal problems. Based on this, the demand is likely to increase for drugs used to manage hypertension.
  • The market is divided into three categories based on distribution channels: online pharmacies, hospital pharmacies, and retail pharmacies. The retail pharmacies segment is accounted to dominate the market over the forecast period. The unhealthy lifestyle patterns have been resulting in increasing glowing obesity and cardiovascular diseases. As such drugs are prescribed on a regular basis to maintain the blood pressure. Additionally, rising cases of cardiovascular diseases such as congenital heart disease, heart failure, hypertension, and heart attacks are fueling the expansion of retail medicine owing to increase abundance and high consumption in the market.

Calcium Channel Blockers Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Calcium Channel Blockers Market- Competitive Landscape:

The presence of local and global companies makes the calcium channel blocker market moderately competitive. The major players are focusing on numerous growth strategies such as collaborations, product launches, and acquisitions, which are contributing constantly to the growth of the calcium channel blocker globally. Moreover, with the increasing cases of cardiovascular disease across the world, key players are investing amounts to develop new therapeutics and sustain themselves in the market. The improved healthcare infrastructure is raising the demand for the calcium channel blocker. For instance, in February 2022, FDA approved CMP Pharma's Norliqva oral solution. Additionally, the solution helps to treat hypertension, to lower blood pressure in adults & children 6 years of age. Norliqva comes in 150 mL bottles, which have 36-month dating

Recent Developments:

For instance, in May 2021, Milestone Pharmaceuticals, Inc. a biopharmaceutical company released positive topline safety and efficacy data from the Etripamil Phase 3 RAPID clinical trial. Additionally, the company's investigational calcium channel blocker in patients with paroxysmal supraventricular tachycardia (PSVT).

Key features of the study:

  • This proposed research study on calcium channel blockers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the calcium channel blockers market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for calcium channel blockers market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the calcium channel blockers market.
  • Impact of COVID-19 on calcium channel blockers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on calcium channel blockers market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the calcium channel blockers market, we have also included competitive landscape and key innovator analysis for the calcium channel blockers market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the calcium channel blockers market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global calcium channel blockers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET KEY PLAYERS

  • Bayer
  • Sanofi
  • Wyeth-Ayerst
  • ClearSynth
  • AbMole Bioscience
  • Pfizer
  • Lupin Pharmaceuticals, Inc.
  • Searle
  • Knoll Pharmaceuticals
  • GlaxoSmithKline Plc.
  • Aventis
  • AstraZeneca
  • Novartis

GLOBALCALCIUM CHANNEL BLOCKERS MARKET, BY DRUG CLASS

  • Dihydropyridine
  • Phenylalkylamine
  • Benzothizepine

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY APPLICATION

  • Angina
  • Hypertension
  • Hypertrophic Cardiomyopathy
  • Arrhythmia
  • Others

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY DISTRIBUTION CHANNEL

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Calcium Channel Blockers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Calcium Channel Blockers Market Snippet by Drug Class
    • 2.1.2. Calcium Channel Blockers Market Snippet by Application
    • 2.1.3. Calcium Channel Blockers Market Snippet by Distribution Channel
    • 2.1.4. Calcium Channel Blockers Market Snippet by Country
    • 2.1.5. Calcium Channel Blockers Market Snippet by Region
  • 2.2. Competitive Insights

3. Calcium Channel Blockers Key Market Trends

  • 3.1. Calcium Channel Blockers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Calcium Channel Blockers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Calcium Channel Blockers Market Opportunities
  • 3.4. Calcium Channel Blockers Market Future Trends

4. Calcium Channel Blockers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Calcium Channel Blockers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Calcium Channel Blockers Market Landscape

  • 6.1. Calcium Channel Blockers Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Calcium Channel Blockers Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
    • 7.1.2. Dihydropyridine
    • 7.1.3. Phenylalkylamine
    • 7.1.4. Benzothizepine

8. Calcium Channel Blockers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Angina
    • 8.1.3. Hypertension
    • 8.1.4. Hypertrophic Cardiomyopathy
    • 8.1.5. Arrhythmia
    • 8.1.6. Others

9. Calcium Channel Blockers Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Online Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Retail Pharmacies

10. Calcium Channel Blockers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Calcium Channel Blockers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Calcium Channel Blockers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Calcium Channel Blockers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Calcium Channel Blockers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Calcium Channel Blockers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Calcium Channel Blockers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Bayer
    • 11.2.2. Sanofi
    • 11.2.3. Wyeth-Ayerst
    • 11.2.4. ClearSynth
    • 11.2.5. AbMole Bioscience
    • 11.2.6. Pfizer
    • 11.2.7. Lupin Pharmaceuticals, Inc.
    • 11.2.8. Searle
    • 11.2.9. Knoll Pharmaceuticals
    • 11.2.10. GlaxoSmithKline Plc.
    • 11.2.11. Aventis
    • 11.2.12. AstraZeneca
    • 11.2.13. Novartis

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Calcium Channel Blockers Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Calcium Channel Blockers Market, by Drug Class2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Calcium Channel Blockers Market, by Application2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Calcium Channel Blockers Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Calcium Channel Blockers Market, by Region 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE EuropeCalcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)